Navigation Links
Advanced therapy offers cure for relapsed cancer patient

INDIANAPOLIS -- Testicular cancer patients who do not respond to traditional therapy can be cured with high-dose chemotherapy and a stem cell transplant, according to an Indiana University School of Medicine report in the July 26 issue of the New England Journal of Medicine.

About 90 percent of testicular cancer patients respond to traditional therapy, which involves multiple courses of cisplatin, first used successfully in the treatment of this disease by Lawrence Einhorn, M.D., at Indiana University Cancer Center in the early 1980s. That course of therapy turned a disease from a mostly fatal cancer into one of the more curable forms of cancer for men, who typically are in their 20s when diagnosed with testicular cancer.

It is rare for the NEJM to carry a retrospective study from a single institution that is not a randomized study. This review looks at the outcome of 184 patients with metastatic testicular cancer. Dr. Einhorn and colleagues demonstrated that the disease is potentially curable with a high dose chemotherapy and stem cell transplant using cells harvested from the patient before the initial chemotherapy infusion.

The patients received carboplatin chemotherapy at five times the dosage administered to men receiving initial therapy. A side effect of the high dosage is a reduction of blood cells so a stem cell transplant is given to replenish the body’s immune system through a process similar to a blood transfusion. Three to four weeks later the entire process is repeated.

“The message for patients is that through research, diligence and new technologies there is hope,” said Dr. Einhorn, professor of medicine at the Indiana University Melvin and Bren Simon Cancer Center and the lead author of the study. “The bar is steadily being raised and more patients are being saved.”

“This review confirms that high-dose chemotherapy combined with a stem cell transplant can provide a cure for a group of patients with relaps
'"/>




Page: 1 2

Related medicine news :

1. Innovative device aids in advanced heart failure
2. Advanced STD programs required
3. Light therapy devotes new hope in advanced lung cancer
4. Hope For Patients With Advanced Breast Cancer
5. Race an important links to the risk of advanced colorectal cancer
6. HIV Vaccine Field Trials In Advanced Stage
7. Twin Treatment Could Be Used Increase Survival Rates In Advanced Melanoma
8. NICE supports application of advanced biological therapies as treatment option for acute psoriasis
9. Eddie Thompson Receives Advanced Cancer Treatment
10. PSA Can Predicts The Treatment Response In Advanced Prostate Cancer
11. Rapid Aging of Arteries In People With Advanced Heart Disease

Post Your Comments:
(Date:11/26/2009)... Dr. David Kim of the Live Life Again C... Dallas , is one of a growing number of physicians...rking sites to connect with individuals who are in...t morbid obesity. Dr. Kim is utilizing Facebook to...ut his practice with the community. , ...
(Date:11/25/2009)...CITY,Mo.,Nov.25/PRNewswire/--TheBartleHallConventi...icalcliniconDec.9-10,whenKansasCityhoststhelatesti..., "Thisfreecliniceventhasthepotentialtobethebigg...ustoneandbeheldonweekdaysinsteadofoveraweekend,"Sh...ClinicandpresidentoftheNationalAssociationofFreeCl...
(Date:11/25/2009)...SPRING,Md.,Nov.25/PRNewswire-USNewswire/--Anarticl...rugEvaluationandResearch,titled"ADifficultBalance-...ov.26,2009issueofTheNewEnglandJournalofMedicine. ,...090824/FDALOGO ) ,, Inthearticle,Woodcockdiscus...dicationforthosewhoneeditandmanagingtherisksposedb...
(Date:11/25/2009)...have found evidence of a statistically significant...tients whose estrogen receptor (ER)-positive tumor...at serine-118 (ER-alpha S118-P), according to a br...the Journal of the National Cancer Institute . ,...tant to tamoxifen. Preclinical studies have shown ...
(Date:11/25/2009)... Evaluation and treatment clinics to re...odstock (Vocus) November 25, 2009 -- Centegra Heal...es and H1N1 vaccine shots at four Centegra Primary...ment of vaccine has arrived. The clinics are at CP...Henry and will be open as follows: ,   ...
Breaking Medicine News(10 mins):Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4
...Currently lie detection methods use heart activity... quite accurately for lie detection reports the on...n scientist Pankaj Pasricha at the University of T...own - literally. It has its own well-developed ner...
... The government of India has today assured that th...a) in the country // The government has set...se eye on the on the domestic poultry population a...ose watch on the situation. Extensive surveillance...
... A new study indicates that there maybe gender dif...cer and women who smoke and drink maybe at higher...r Anna L. Zisman, M.D. of Evanston Northwestern He...hol use are well-established risk factors for colo...
...tudy was conducted to investigate the association ... density (BMD), and cardiovascular risk factors. T...her bone mineral // density than the controls, and...diabetics have bone mass alterations and may have ...
...-mediated bone marrow injury is an early or predis...d persistent hematopoietic disease, according to r...r 23 in the journal Leukemia Research. My...s, clonal evolution and a tendency to progress on ...
...ers have been used widely in the treatment of hype...rugs in hypertension guidelines. Moreover, after m...ilure, treatment // with beta blockers prevents re...hypertension. A recent study, published in t...
Other Medicine News:Health News:Women More Prone To Risk of Colorectal Cancer from Tobacco 2Health News:Diabetic Type II Women Have Elevated Bone Density Mass 2Health News:Evidence against use of Beta blockers as first choice in the treatment of primary hypertension 2
(Date:11/25/2009)...ire/--Reportlinker.comannouncesthatanewmarketresea...nagement-GlobalTrends ,, http://www.reportli...html ,, Widespreadavailabilityofgenericdrugs,e...rugshaveacceleratedthepaceofgrowthinthepainmanagem...recontinuetoshapedemandforservices,drugsanddevices...
(Date:11/25/2009)...v.25/PRNewswire/-- ChemoCentryx,Inc.,announcedtod...CT-1(theProspectiveRandomizedOralTherapyEvaluation...npatientswithmoderate-to-severeCrohn,sdiseasedemon...rabilityprofile.Thestudydemonstratedevidenceofclin...edasa70-pointdecreaseintheCrohn,sDiseaseActivityIn...
(Date:11/24/2009)...Newswire-FirstCall/--QuestDiagnosticsIncorporated(...esting,informationandservices,announcedthatitissch...ConferenceinNewYorkCity.Thepresentationisscheduled...,, Duringtheconference,thecompanywillreaffirmit...tingincometoexceed18%ofrevenues,anddilutedearnings...
Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2LightLab 28R 29 Imaging Showcases Advanced OCT System Technology at TCT 2009 57670 1LightLab 28R 29 Imaging Showcases Advanced OCT System Technology at TCT 2009 57670 2LightLab 28R 29 Imaging Showcases Advanced OCT System Technology at TCT 2009 57670 3Accera Inc to Present at UBS Global Life Sciences Conference 57667 1Accera Inc to Present at UBS Global Life Sciences Conference 57667 2Ulcer Preventative May Raise Pneumonia Risks 57664 1Ulcer Preventative May Raise Pneumonia Risks 57664 2
...SINESS WIRE)--Jun 13, 2007 - EPIX,Pharmaceuticals,...m,its Phase 3 trial of PRX-00023, a novel long-act...ntation at the 47th Annual New,Clinical Drug Evalu... The meeting is sponsored by the National Institut...Psychopharmacology., The presentation highlighted ...
...-(BUSINESS WIRE)--Jun 14, 2007 - Can-Fite,BioPharm...he Tel,Aviv Stock Exchange Exchange, proceeds with...in addition to CF101, which is currently,in clinic...s. This,weekend Can-Fite will present at the EUALR...ivo study results showing effective,anti-inflammat...
Other Medicine Technology:EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 2EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 3EPIX Pharmaceuticals Presents Findings from PRX-00023 Phase 3,Clinical Trial at 47th Annual NCDEU Meeting 4Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology 2
HemoCue 201 DM System, Glucose
Triage® C. difficile Panel
Bartels® C. Difficile Toxin A Antigen EIA with Controls
... Toxin A C. difficile Rapid Toxin A Test gives you...minutes. When it might be C. difficile, you can't ...nly a few tests a day or sends out its suspected C...C. difficile Rapid Toxin A Test will cut costs and...
Medicine Products: